Breaking News

CES comes to Washington, telehealth for chronic care, & Medicare's device rule on the way

April 23, 2024
Reporter, STAT Health Tech Writer

Good morning! There's some very spirited debate unfolding on the merits and risks of full-body MRIs sold by a handful of startups including Prenuvo. The topic clearly arouses emotion among advocates and detractors alike, and I doubt they'll converge anytime soon. Thoughts on the rift, and news tips, go to mohana.ravindranath@statnews.com.

lobbying

CES organizer gathers speed in health tech 

Late last week I dropped by Washington's annual "CES on the Hill", a smaller scale, schmoozier version of the Las Vegas showcase organizer by the Consumer Technology Association — this event intends to expose lawmakers and staffers to cutting-edge products. Four of this year's exhibitors touched on health tech, including Dexcom with a demo of its continuous glucose monitor, and EssilorLuxottica, showing off eyeglasses equipped with audio-enhancing technology, marketed as a solution for hearing loss. I tried on the glasses, which reorient the audio enhancement according to where the wearer is looking. (It's a cool feature that certainly helps in a noisy crowd, but can't vouch for how helpful it would be for someone with hearing loss.) The company said it's not yet available on any market, but they're expecting it to hit US shelves by the end of the year.

(Essilor Luxottica's booth, pictured above. The audio product, Nuance, is unrelated to Microsoft's medical documentation subsidiary.) 

CTA's digital health vice president René Quashie told me the trade group sees growing interest among health tech companies eager to influence policy, especially on establishing data privacy standards and removing barriers to telehealth, among other issues. 

Indeed, it's Dexcom's first year at CES on the Hill, having just joined CTA this fall. Global PR director James McIntosh told me the company is especially interested in expanding access and reimbursement for continuous glucose monitors, in addition to AI standards for health care, and potentially reducing its waste including by using electronic instructions instead of printed copies, as it's currently required to distribute. Just last month, the company got the green light from the FDA for the first over-the-counter continuous glucose monitor


Cybersecurity 

Change Healthcare: It gets worse, somehow

Yesterday UnitedHealth announced that the stolen files from February's Change Healthcare cyberattack include protected health information and "could cover a substantial proportion of people in America," my health tech colleague Brittany Trang tells us. 

It'll likely take months for UnitedHealth to identify and notify affected people; the company said it'll make the notifications on behalf of providers, assuaging concerns from groups such as the American Hospital Association.

Addressing allegations that the stolen patient data was up for sale on the dark web, UnitedHealth said 22 screenshots, some of which contained sensitive information from the stolen files, were "posted for about a week on the dark web by a malicious threat actor," but that no more leaks have occurred.

In the meantime, UnitedHealth stood up a website and call center for information and free credit monitoring and identity theft protections for two years. Separately, our colleagues over at Bloomberg confirmed that UnitedHealth did indeed pay the ransom "as part of the company's commitment to do all it could to protect patient data from disclosure."


Telehealth

Inside new Joint Commission, NCQA standards

Accreditation body the  Joint Commission is announcing a new standard for virtual care that it plans to launch on July 1, and the National Committee for Quality Assurance has said its own standards will be unveiled later that month, my colleague Katie Palmer writes today. 

"We want to elevate best practices to the top, call out quality when we see it, and help other organizations to create really lasting and quality systems for the delivery of virtual care," said Claire Mendelson, an NCQA product manager who's worked on its virtual care program.

"[A]s the use of telehealth has rapidly expanded into new health care settings and specialties, we did identify the need to create a new program that provides updated, streamlined standards,"the Joint Commission's Tina Cordero said. 

These standards will include requirements for credentialing medication management, and leadership structure, among other areas. Read more from Katie


Is chronic care telehealth's golden opportunity?

STAT's chronic disease reporter Isabella Cueto's latest, deeply reported story explores the myriad ways virtual care could be a boon for chronic disease patients whose conditions make it all the more difficult to get care in-person. And, unsurprisingly, there's a growing crop of startups ready to capitalize on that opportunity. 

People experiencing fatigue or exhaustion, for instance, can preserve energy by doing a video call instead of trekking to the doctor's office; avoiding in-person exams could offer crucial protection for patients taking immunosuppressive drugs. Read more from Isa



genetic testing

23andme CEO Anne Wojcicki moves to go private

The head of beleaguered DNA testing kit giant 23andMe disclosed plans in a Securities and Exchange Commission filing late last week to take the company private following its rough go on the public market, my biotech colleague Allison DeAngelis reports. Anne Wojcicki said in the filing she plans to find partners and financiers to help — at Monday's close of 48 cents a share, the company had a market capitalization of about $220 million. 

The company made its name with at-home genetic testing kids, but its visionary CEO has tried to market the insights derived from those tests — and millions of genetic samples — as a means for creating new treatments. But it had just about a year's worth of expenses stashed away by the end of last year, and its stock has tumbled since its 2021 peak. Read more from Allison


Lizzy's device digest

Medicare and breakthrough device reimbursement

A closely watched initiative designed to make payment for breakthrough medical devices easier is expected to land in the summer, Lizzy Lawrence reports. The Centers for Medicare & Medicaid Services has been under intense pressure from device makers eager for faster reimbursement decisions. Late last week, CMS' clinical standards center director Dora Hughes  told Medical Device Manufacturers' Association conference attendees the agency needed time to review feedback on the proposed rule, whose public comment period closed in August. Read more from Lizzy on the rule and what it means. 


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Change hackers broke in 9 days before attack, WSJ
  • AI could help meet FDA's diversity requirements, STAT
  • Telehealth's impact on utilization and spending, Health Affairs

Thanks for reading! More on Thursday - Mohana

Mohana Ravindranath is a Bay Area correspondent covering health tech at STAT and has made it her mission to separate out hype from reality in health care.


Enjoying STAT Health Tech? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments